NCT05218148 2022-04-06
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Unknown
ChineseAMS
Huabo Biopharm Co., Ltd.
National Cancer Centre, Singapore
SuZhou Stainwei Biotech Inc.
National Cancer Institute (NCI)